Condition: Healthy · Sponsor: University Hospital, Basel, Switzerland
The primary objective of this study is to determine whether equivalent moderately high doses of LSD, psilocybin, and DMT produce qualitatively similar peak effects when the effect duration is standardized with ketanserin. A DMT infusion mimicking oral LSD and psilocybin administrations will be tested, as well as intravenously administered ketanserin.
This description comes directly from the study's public registry record.
Matthias E Liechti, Prof. Dr. MD · 61 328 68 68 · matthias.liechti@usb.ch
Mélusine Humbert-Droz, MSc · 61 328 48 19 · melusine.humbert-droz@usb.ch
Always discuss trial participation with your own doctor first.
| University Hospital | Basel, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06899334